Bezlotoxumab - in "Real Life" - During the First Episode of Clostridium Difficile Infection in Patients With High Risk of Recurrence.
Clinical trial NCT04075422 · COMPLETED
Trial details
- NCT number
- NCT04075422
- Sponsor
- Fundacion SEIMC-GESIDA
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-10-01
- Primary completion
- 2021-08-05
- Enrollment
- 869
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.